Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment
Antiarrythmic therapy is one of the most problematic areas of modern medicine, with a constant search for new, more effective and safe medications. One of these new agents is dronedarone — a Class III antiarrythmic drug, with a structure similar to that of amiodarone, but without iodine in its molec...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2010-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2152 |